Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series.

Publikation

Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series.

Wissenschaftlicher Artikel/Review - 15.04.2022

Rüfenacht Susanne, Gantenbein Pascal, Boggian Katia, Flury Domenica, Kern Lukas, Dollenmaier Günter, Kohler Philipp, Albrich Werner

Zitation

Rüfenacht S, Gantenbein P, Boggian K, Flury D, Kern L, Dollenmaier G, Kohler P, Albrich W. Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series. Infection 2022; 50:783-790.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Infection 2022; 50

Veröffentlichungsdatum

15.04.2022

eISSN (Online)

1439-0973

Seiten

783-790

Kurzbeschreibung/Zielsetzung

COVID-19 patients on anti-CD20 treatment can suffer a delayed viral clearance and worse clinical outcome. We aim to present our experience with remdesivir treatment in anti-CD20-treated patients with prolonged symptoms, a patient population for which no data from randomized controlled trials are available.